Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05026645 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Medical Management in Patients Exposed to Weapons of Mass Destruction

Study acronym: CBRNEObs
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Site details revised at 2 of 15 sitesv12
  2. Minor Site details revised at 2 of 15 sitesv11
  3. Minor Study sites: 14 to 15v10
  4. Minor Study sites: 12 to 14v9
  5. Minor Site details revised at 2 of 12 sitesv8
Show 6 earlier versionsHide 6 earlier versions
  1. Notable Primary completion date: Oct 1, 2023 to Nov 1, 2036
    • Study completion date: Oct 1, 2035 to Dec 1, 2036
    v7
  2. Minor Study sites revised (12)
    • Collaborators: 19 to 9
    • Study title revised
    v6
  3. Minor Study sites: 10 to 12
    • Collaborators: 17 to 19
    v5
  4. Minor Study sites: 7 to 10v4 Show 4 more changesShow less
    • Eligibility criteria shortened, about 16 words
    • Collaborators: 12 to 17
    • Study description expanded, about 5 words
    • Study title expanded, about 2 words
  5. Minor Study sites: 1 to 7
    • Collaborators: 6 to 12
    v3
  6. Minor Eligibility criteria expanded, about 14 wordsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Observation study measuring medical response in contaminated environment.
Trial Details
NCT Number NCT05026645
Lead Sponsor St. Justine's Hospital
Collaborators: Quebec Heart and Lung Institute, Quebec City, Canada, Sorbonne University, Medical Intelligence CBRNE inc.; Quebec City, Canada, Department of Intensive Care Medicine, Tokyo, Japan, Centre for Defence and Security Studies, University of Manitoba, Winnipeg, Canada, Biomedical Telematics Laboratory, Quebec Respiratory Health Research Network, Sherbrooke, Canada, Tokyo University, Tokyo Women's Medical University, University of Maryland, College Park
Conditions
(from sponsor)
Chemical Injury, Chemicals; Intoxication, Acute Respiratory Distress Syndrome, Distress Respiratory Syndrome, Medical Emergencies
Related terms Pulmonary Atelectasis, Respiratory Distress Syndrome
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov